The February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk:
Early Response is Associated With Stable Long-Term Response in Psoriasis Patients Receiving Ixekizumab or Ustekinumab focuses on a significant factor in maintaining stable complete or almost complete skin clearance.
Results from the workgroup are covered in 2020 IDEOM Annual Meeting: Actinic Keratosis Stakeholders Survey Identifies Gaps in Research and Care.
Perceptions of Artificial Intelligence Integration into Dermatology Clinical Practice: A Cross-Sectional Survey Study concludes that doctors are generally receptive.
Histopathological Changes Induced by Malassezin: A Novel Natural Microbiome Indole for Treatment of Facial Hyperpigmentation documents the study in which subjects underwent twice-daily application.
Treatment of Nail Psoriasis summarizes options available for this diagnosis.
Authors test MMF as both a monotherapy and dual therapy in The Use of Mycophenolate Mofetil in the Treatment of Bullous Pemphigoid
Platelet Count, Mean Platelet Volume, and Red Cell Distribution Width as Markers for Psoriasis Severity is a cross-sectional study of 120 patients.
Participants report a positive experience in Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With Psoriasis
In The Heterogeneity of Atopic Dermatitis, the authors conducted a focused review of the published literature, including retrospective, observational, and prospective studies, clinical trials, and consensus guidelines.
In A Systematic Review: Application of Rice Products for Hair Growth, authors deem current literature promising after analyzing 10 articles.
Intralesional Mode of Drug Administration in Psoriasis attempts to review all the possible drugs and indications where this method is feasible.
Artificial Intelligence in the Evaluation of Telemedicine Dermatology Patients determines that AI identification did not significantly differ from that of board-certified dermatologists.
The case study Intralesional Bleomycin Combined With Cryotherapy in the Treatment of Recalcitrant Verruca Vulgaris supports this option based on results in a 64-year-old patient.
Nonresponse and Progression of Diffuse Keloids to Dupilumab Therapy presents a case report with two 17-year-old patients.
A Rare Case of Empedobacter Brevis Cutaneous Infection Treated Successfully With Oral Sarecycline discusses a 61-year-old patient with this condition.
Most Patient-Oriented Video Resources Do Not Comprehensively Explain Mohs Micrographic Surgery highlights the importance of accurately explaining MMS at the time of skin cancer diagnosis.
Experience of a Single Academic Center Using IL-1 Inhibition for Rare Dermatologic Conditions seeks to better characterize cases where these medications could be utilized.
Disparities in Telemedicine Satisfaction Among Older and Non-White Dermatology Patients: A Cross-Sectional Study offers the findings from a pre/post-consultation questionnaire.
Find more JDD Issue Highlights here.
